Impact of a new vaccine clinic on hepatitis B vaccine completion and immunological response rates in an HIV-positive cohort

Summary: Introduction: Hepatitis B virus vaccination (HBVV) in the HIV-infected population has poor reported completion rates and immunological response rates. At our HIV clinic, we established a vaccine clinic to improve HBVV outcomes using interventions such as SMS text reminders and double-dose...

Full description

Bibliographic Details
Main Authors: Clare Rock, Eoghan de Barra, Corinna Sadlier, Sinead Kelly, Catherine Dowling, Cora McNally, Colm Bergin
Format: Article
Language:English
Published: Elsevier 2013-06-01
Series:Journal of Infection and Public Health
Online Access:http://www.sciencedirect.com/science/article/pii/S1876034112001748
_version_ 1818947803246755840
author Clare Rock
Eoghan de Barra
Corinna Sadlier
Sinead Kelly
Catherine Dowling
Cora McNally
Colm Bergin
author_facet Clare Rock
Eoghan de Barra
Corinna Sadlier
Sinead Kelly
Catherine Dowling
Cora McNally
Colm Bergin
author_sort Clare Rock
collection DOAJ
description Summary: Introduction: Hepatitis B virus vaccination (HBVV) in the HIV-infected population has poor reported completion rates and immunological response rates. At our HIV clinic, we established a vaccine clinic to improve HBVV outcomes using interventions such as SMS text reminders and double-dose (DD) HBVV for standard-dose non-responders (SD NRs). Methods: A five-year (2003–2008) retrospective review of the completion rates and immunological response rates for HBVV after the establishment of the dedicated vaccine clinic was conducted. Statistical significance was assumed at p < 0.05, and the analysis was performed using SPSS (v16). Results: A total of 354 HIV-infected patients were included. Seventy-five percent (268/354) of patients completed the SD HBVV, an 84% (226/268) returned for the hepatitis B surface antibody evaluation. Only 47.3% (107/226) responded to standard-dose hepatitis B vaccination. Responders had higher absolute numbers (p = 0.017) and percentages of CD4 cells (p < 0.001) and were more likely to be receiving HAART (p = 0.001). There was a 70% (48/69) response rate to DD HBVV among SD NRs. On-treatment analysis showed an 88% (155/176) overall immunological response to SD HBVV and DD HBVV, if required. Conclusion: High HBVV completion and response rates in this HIV cohort were enabled through the use of multiple interventions, including the use of SMS text message reminders and routine referral for DD vaccination. Keywords: Hepatitis B, HIV, Hepatitis B vaccination, Hepatitis B vaccination outcomes
first_indexed 2024-12-20T08:36:42Z
format Article
id doaj.art-b8f199a93d5b4defb68d29f0ce9de644
institution Directory Open Access Journal
issn 1876-0341
language English
last_indexed 2024-12-20T08:36:42Z
publishDate 2013-06-01
publisher Elsevier
record_format Article
series Journal of Infection and Public Health
spelling doaj.art-b8f199a93d5b4defb68d29f0ce9de6442022-12-21T19:46:33ZengElsevierJournal of Infection and Public Health1876-03412013-06-0163173178Impact of a new vaccine clinic on hepatitis B vaccine completion and immunological response rates in an HIV-positive cohortClare Rock0Eoghan de Barra1Corinna Sadlier2Sinead Kelly3Catherine Dowling4Cora McNally5Colm Bergin6Department of Infectious Diseases, University of Maryland, Baltimore, MD 21201, USA; Corresponding author. Tel.: +1 4438313602.Department of Genitourinary Medicine and Infectious Diseases, St. James Hospital, Dublin 8, IrelandDepartment of Genitourinary Medicine and Infectious Diseases, St. James Hospital, Dublin 8, IrelandDepartment of Genitourinary Medicine and Infectious Diseases, St. James Hospital, Dublin 8, IrelandDepartment of Genitourinary Medicine and Infectious Diseases, St. James Hospital, Dublin 8, IrelandDepartment of Genitourinary Medicine and Infectious Diseases, St. James Hospital, Dublin 8, IrelandDepartment of Genitourinary Medicine and Infectious Diseases, St. James Hospital, Dublin 8, IrelandSummary: Introduction: Hepatitis B virus vaccination (HBVV) in the HIV-infected population has poor reported completion rates and immunological response rates. At our HIV clinic, we established a vaccine clinic to improve HBVV outcomes using interventions such as SMS text reminders and double-dose (DD) HBVV for standard-dose non-responders (SD NRs). Methods: A five-year (2003–2008) retrospective review of the completion rates and immunological response rates for HBVV after the establishment of the dedicated vaccine clinic was conducted. Statistical significance was assumed at p < 0.05, and the analysis was performed using SPSS (v16). Results: A total of 354 HIV-infected patients were included. Seventy-five percent (268/354) of patients completed the SD HBVV, an 84% (226/268) returned for the hepatitis B surface antibody evaluation. Only 47.3% (107/226) responded to standard-dose hepatitis B vaccination. Responders had higher absolute numbers (p = 0.017) and percentages of CD4 cells (p < 0.001) and were more likely to be receiving HAART (p = 0.001). There was a 70% (48/69) response rate to DD HBVV among SD NRs. On-treatment analysis showed an 88% (155/176) overall immunological response to SD HBVV and DD HBVV, if required. Conclusion: High HBVV completion and response rates in this HIV cohort were enabled through the use of multiple interventions, including the use of SMS text message reminders and routine referral for DD vaccination. Keywords: Hepatitis B, HIV, Hepatitis B vaccination, Hepatitis B vaccination outcomeshttp://www.sciencedirect.com/science/article/pii/S1876034112001748
spellingShingle Clare Rock
Eoghan de Barra
Corinna Sadlier
Sinead Kelly
Catherine Dowling
Cora McNally
Colm Bergin
Impact of a new vaccine clinic on hepatitis B vaccine completion and immunological response rates in an HIV-positive cohort
Journal of Infection and Public Health
title Impact of a new vaccine clinic on hepatitis B vaccine completion and immunological response rates in an HIV-positive cohort
title_full Impact of a new vaccine clinic on hepatitis B vaccine completion and immunological response rates in an HIV-positive cohort
title_fullStr Impact of a new vaccine clinic on hepatitis B vaccine completion and immunological response rates in an HIV-positive cohort
title_full_unstemmed Impact of a new vaccine clinic on hepatitis B vaccine completion and immunological response rates in an HIV-positive cohort
title_short Impact of a new vaccine clinic on hepatitis B vaccine completion and immunological response rates in an HIV-positive cohort
title_sort impact of a new vaccine clinic on hepatitis b vaccine completion and immunological response rates in an hiv positive cohort
url http://www.sciencedirect.com/science/article/pii/S1876034112001748
work_keys_str_mv AT clarerock impactofanewvaccinecliniconhepatitisbvaccinecompletionandimmunologicalresponseratesinanhivpositivecohort
AT eoghandebarra impactofanewvaccinecliniconhepatitisbvaccinecompletionandimmunologicalresponseratesinanhivpositivecohort
AT corinnasadlier impactofanewvaccinecliniconhepatitisbvaccinecompletionandimmunologicalresponseratesinanhivpositivecohort
AT sineadkelly impactofanewvaccinecliniconhepatitisbvaccinecompletionandimmunologicalresponseratesinanhivpositivecohort
AT catherinedowling impactofanewvaccinecliniconhepatitisbvaccinecompletionandimmunologicalresponseratesinanhivpositivecohort
AT coramcnally impactofanewvaccinecliniconhepatitisbvaccinecompletionandimmunologicalresponseratesinanhivpositivecohort
AT colmbergin impactofanewvaccinecliniconhepatitisbvaccinecompletionandimmunologicalresponseratesinanhivpositivecohort